CN101337045A - Traditional Chinese medicine for treating hyperplasia of mammary glands - Google Patents
Traditional Chinese medicine for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN101337045A CN101337045A CNA2008100792363A CN200810079236A CN101337045A CN 101337045 A CN101337045 A CN 101337045A CN A2008100792363 A CNA2008100792363 A CN A2008100792363A CN 200810079236 A CN200810079236 A CN 200810079236A CN 101337045 A CN101337045 A CN 101337045A
- Authority
- CN
- China
- Prior art keywords
- grams
- fructus
- chinese medicine
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 210000005075 mammary gland Anatomy 0.000 title abstract description 4
- 206010020718 hyperplasia Diseases 0.000 title abstract 3
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000006187 pill Substances 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000283956 Manis Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 23
- 230000008901 benefit Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000030270 breast disease Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine for curing hyperplasia of mammary glands, and belongs to a medicament prepared from the traditional Chinese medicine materials based on the preparation method of capsules, powder or pills. The invention mainly solves the technical difficulties that the prior therapeutic method has great side effect on human body, and can not eradicate the diseases. The technical proposal is as follows: according to the preparation method of capsules, powder or pills, the traditional Chinese medicine for curing hyperplasia of mammary glands comprises the following raw materials by weight part: 3 to 5 g of bupleurum, 12 to 18 g of membranous milk vetch root, 4 to 8 g of cowherb seed, 3 to 5 g of pangolin, 2 to 5 g of sweetgum fruit, 2 to 4 g of gleditschia xylocarpa hance, 4 to 8 g of salvia miltiorrhiza, 6 to 10 g of Chinese angelica root, 4 to 8 g of red paeonia, 3 to 5 g of rhizoma sparganii, 3 to 5 g of rhizoma zedoariae, 3 to 5 g of fructus meliae toosendan, 3 to 5 g of fingered citron, 3 to 5 g of bitter orange and 3 to 5 g of fructus psoraleae. The traditional Chinese medicine has the advantages of good curative effect, convenient administration, immediate effect and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine medicine for the treatment of cyclomastopathy, it belongs to a kind of medicine of being made by capsule, powder or pill preparation method by raw material of Chinese medicine.
Background technology
Cyclomastopathy is a kind of common female diseases, and annual whole mankind women loses perfect breast because of suffering from cyclomastopathy, even the absolute number of dying constantly rising, and mastopathy is seriously endangering the healthy of women.Modern medicine is thought cyclomastopathy mainly by endocrine hormone off-leveling in the body, the estrogen secretion surplus, and liver deactivation estrogen function is unusual in addition, makes too much estrogen carry out bad stimulation to mammary gland tissue and causes the mammoplasia sexually transmitted disease (STD) to become.The traditional Chinese medical science thinks that primary disease is because feelings will is not relaxed, depression of liver-QI, and QI-blood circulation does not freely cause the stagnation of QI expectorant blood coagulation stasis of blood; The expectorant stasis of blood stagnates in breast, and stasis of blood knot does not loose, and accumulating over a long period forms, and patient shows as mastalgia mostly, based on distending pain, distending pain is everlasting and is increased the weight of before the menstrual onset, alleviates gradually after the menstruation, even disappear, pain often relates to oxter and shoulder back, or pain changes along with anxious state of mind.Now both at home and abroad the method for treatment cyclomastopathy mainly is to adopt operation directly to extract, though this method the focus of cyclomastopathy can be dispeled, big to the side effect of health, can not thoroughly eradicate.
Summary of the invention
The objective of the invention is to solve the problems of the technologies described above and provide a kind of Chinese medicine medicine of the treatment cyclomastopathy that makes the cyclomastopathy patient exempt operation misery, good effect and have no side effect.
The present invention solves the problems of the technologies described above the technical scheme that adopts to be: the Chinese medicine medicine of treatment cyclomastopathy, it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 3～5 grams, the Radix Astragali 12～18 grams, Semen Vaccariae 4～8 grams, Squama Manis 3～5 grams, Fructus Liquidambaris 2～5 grams, Spina Gleditsiae 2～4 grams, Radix Salviae Miltiorrhizae 4～8 grams, Radix Angelicae Sinensis 6～10 grams, Radix Paeoniae Rubra 4～8 grams, rhizoma sparganic 3～5 grams, Rhizoma Curcumae 3～5 grams, Fructus Toosendan 3～5 grams, Fructus Citri Sarcodactylis 3～5 grams, Fructus Aurantii 3～5 grams, Fructus Psoraleae 3～5 grams.
Optimum weight proportioning of the present invention is: Radix Bupleuri 3 grams, the Radix Astragali 15 grams, Semen Vaccariae 6 grams, Squama Manis 3 grams, Fructus Liquidambaris 4 grams, Spina Gleditsiae 3 grams, Radix Salviae Miltiorrhizae 6 grams, Radix Angelicae Sinensis 8 grams, Radix Paeoniae Rubra 6 grams, rhizoma sparganic 3 grams, Rhizoma Curcumae 3 grams, Fructus Toosendan 3 grams, Fructus Citri Sarcodactylis 3 grams, Fructus Aurantii 3 grams, Fructus Psoraleae 3 grams.
Radix Bupleuri in the prescription of the present invention has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy, is monarch drug in prescription.The Radix Astragali has the spleen invigorating invigorating middle warmer, rises the cloudy effect sunken, that benefit is defended consolidating superficial resistance, diuresis, promoting pus discharge and tissue regeneration strengthening of lifting, and is ministerial drug in prescription.Semen Vaccariae has the disappear effect of pain, inducing diuresis for treating stranguria syndrome of promoting blood circulation to restore menstrual flow, stimulating milk secretion, Squama Manis has the eliminating mass of invigorating blood circulation, the stimulating milk secretion of stimulating the menstrual flow, the detumescence toxin expelling effect, Fructus Liquidambaris has the effect that dispelling, collateral-activating, diuretic stimulate the menstrual flow, Spina Gleditsiae has the effect of the pertinacious phlegm of dispelling, sensible switching, Radix Salviae Miltiorrhizae has the disappear effect of pain of promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood, rhizoma sparganic and Rhizoma Curcumae have the effect of removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving, and above-mentioned seven flavor Chinese medicines are adjuvant drug in prescription.Radix Angelicae Sinensis has the effect of tonifying blood and regulating menstruation, promoting blood circulation and stopping pain, loosening bowel to relieve constipation, Radix Paeoniae Rubra has the effect of clearing away heat and cooling blood, eliminating stasis to stop pain, Fructus Toosendan has the effect of promoting the circulation of QI to relieve pain, Fructus Citri Sarcodactylis has dispersing the stagnated live-QI to relieve the stagnation of QI, regulate the flow of vital energy and in, the effect of drying dampness to eliminate phlegm, Fructus Aurantii has the effect that dispelling the stagnated QI removes painful abdominal mass, transforming phlegm and dispersing accumulations, and Fructus Psoraleae has the effect of kidney invigorating and YANG supporting, controlling nocturnal emission with astringent drugs reducing urination, wet spleen antidiarrheal, helping inspiration to relieve asthma; Above-mentioned Six-element Chinese medicine is messenger drug in prescription.
The present invention presses the theory of Chinese medical science prescription according to the cognition of motherland's medical science to cyclomastopathy, and makes Chinese patent medicine by capsule, powder or pill preparation method, and the treatment cyclomastopathy has better curative effect.
Medicine of the present invention has the blood circulation promoting and dispersing pathogen accumulation softening the hard mass, and liver-smoothing, qi-regulating reduces phlegm, and the effect of QI invigorating heat-clearing and toxic substances removing has antitumaous effect by regulating human body immune function simultaneously, and it is painful and stop the breast disease patient that the danger of canceration takes place to make the breast disease patient exempt operation.Through 4000 many cases clinical practices, 99.8% is effective, and cure rate reaches 97.8%, and average curative day is 45 days.Therefore, compare with background technology, the present invention has the curative effect height, and is easy to use, the very fast and advantage that has no side effect of onset.
The specific embodiment
The present invention is described in further detail below in conjunction with embodiment.
Embodiment 1
The Chinese medicine medicine of the treatment cyclomastopathy in the present embodiment, it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 3 grams, the Radix Astragali 15 grams, Semen Vaccariae 6 grams, Squama Manis 3 grams, Fructus Liquidambaris 4 grams, Spina Gleditsiae 3 grams, Radix Salviae Miltiorrhizae 6 grams, Radix Angelicae Sinensis 8 grams, Radix Paeoniae Rubra 6 grams, rhizoma sparganic 3 grams, Rhizoma Curcumae 3 grams, Fructus Toosendan 3 grams, Fructus Citri Sarcodactylis 3 grams, Fructus Aurantii 3 grams, Fructus Psoraleae 3 grams.
The method of the Chinese medicine medicine of production for treating cyclomastopathy is in the present embodiment: at first take by weighing raw material by above-mentioned weight proportion, then Squama Manis is concocted into Squama Manis, the Semen Vaccariae quick-fried is become the Semen Vaccariae puffed rice, then with above-mentioned Chinese medicine mix homogeneously, be ground into 120 purpose fine powders through pulverizer, fine powder incapsulated promptly make capsule preparations in the shell.
Usage: a twice-daily, each 35 the gram, early, the evening hollow taking.
Embodiment 2
The Chinese medicine medicine of the treatment cyclomastopathy in the present embodiment, it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 5 grams, the Radix Astragali 12 grams, Semen Vaccariae 4 grams, Squama Manis 5 grams, Fructus Liquidambaris 2 grams, Spina Gleditsiae 2 grams, Radix Salviae Miltiorrhizae 4 grams, Radix Angelicae Sinensis 10 grams, Radix Paeoniae Rubra 4 grams, rhizoma sparganic 5 grams, Rhizoma Curcumae 4 grams, Fructus Toosendan 4 grams, Fructus Citri Sarcodactylis 5 grams, Fructus Aurantii 4 grams, Fructus Psoraleae 5 grams.
The production method of present embodiment is with the production method among the embodiment 1.
Usage is with the usage among the embodiment 1.
Embodiment 3
The Chinese medicine medicine of the treatment cyclomastopathy in the present embodiment, it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 4 grams, the Radix Astragali 18 grams, Semen Vaccariae 8 grams, Squama Manis 4 grams, Fructus Liquidambaris 5 grams, Spina Gleditsiae 4 grams, Radix Salviae Miltiorrhizae 8 grams, Radix Angelicae Sinensis 6 grams, Radix Paeoniae Rubra 8 grams, rhizoma sparganic 4 grams, Rhizoma Curcumae 5 grams, Fructus Toosendan 5 grams, Fructus Citri Sarcodactylis 4 grams, Fructus Aurantii 5 grams, Fructus Psoraleae 4 grams.
The production method of present embodiment is with the production method among the embodiment 1.
Usage is with the usage among the embodiment 1.
Medicine in the foregoing description can also be made powder or pill by the preparation method of powder or pill.
Claims (2)
1, a kind of Chinese medicine medicine for the treatment of cyclomastopathy is characterized in that: it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 3～5 grams, the Radix Astragali 12～18 grams, Semen Vaccariae 4～8 grams, Squama Manis 3～5 grams, Fructus Liquidambaris 2～5 grams, Spina Gleditsiae 2～4 grams, Radix Salviae Miltiorrhizae 4～8 grams, Radix Angelicae Sinensis 6～10 grams, Radix Paeoniae Rubra 4～8 grams, rhizoma sparganic 3～5 grams, Rhizoma Curcumae 3～5 grams, Fructus Toosendan 3～5 grams, Fructus Citri Sarcodactylis 3～5 grams, Fructus Aurantii 3～5 grams, Fructus Psoraleae 3～5 grams.
2, a kind of Chinese medicine medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: it is the medicament of being made by capsule, powder or pill preparation method by the following weight proportion raw material: Radix Bupleuri 3 grams, the Radix Astragali 15 grams, Semen Vaccariae 6 grams, Squama Manis 3 grams, Fructus Liquidambaris 4 grams, Spina Gleditsiae 3 grams, Radix Salviae Miltiorrhizae 6 grams, Radix Angelicae Sinensis 8 grams, Radix Paeoniae Rubra 6 grams, rhizoma sparganic 3 grams, Rhizoma Curcumae 3 grams, Fructus Toosendan 3 grams, Fructus Citri Sarcodactylis 3 grams, Fructus Aurantii 3 grams, Fructus Psoraleae 3 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100792363A CN101337045B (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100792363A CN101337045B (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101337045A true CN101337045A (en) | 2009-01-07 |
| CN101337045B CN101337045B (en) | 2011-06-22 |
Family
ID=40211310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100792363A Active CN101337045B (en) | 2008-08-19 | 2008-08-19 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101337045B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102120021A (en) * | 2011-03-11 | 2011-07-13 | 雷允上药业有限公司 | Detection method of concentrated pills for treating hyperplastic disease of breast |
| CN102657814A (en) * | 2012-05-08 | 2012-09-12 | 华诚睿光（北京）科技发展有限公司 | Chinese medicinal preparation for treating intractable hyperplastic mastitis and preparation method thereof |
| CN104940483A (en) * | 2015-06-11 | 2015-09-30 | 宗秀红 | Traditional Chinese medicine for treating phlegm and blood stagnation type breast hyperplasia, and preparation method thereof |
| CN105194573A (en) * | 2015-11-03 | 2015-12-30 | 曹涛 | Traditional Chinese medicine patch for treating mammary gland diseases and promoting firmness of mammary glands |
| CN105944026A (en) * | 2016-06-24 | 2016-09-21 | 贵州盛世保康茶开发有限公司 | Miao-national medicine for treating hyperplasia of mammary glands |
| CN109078154A (en) * | 2018-10-31 | 2018-12-25 | 中山市六安堂健康管理有限公司 | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland |
| CN109381663A (en) * | 2017-08-08 | 2019-02-26 | 张君超 | A kind of Chinese medicine composition and preparation method thereof for treating the proliferation of mammary gland |
| CN114259550A (en) * | 2021-09-29 | 2022-04-01 | 哈尔滨康奇特科技有限公司 | Chinese medicinal prescription for preventing and treating breast diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060664C (en) * | 1996-07-15 | 2001-01-17 | 鲍树伟 | Chinese drug for curing and preventing mastosis and its preparing method |
-
2008
- 2008-08-19 CN CN2008100792363A patent/CN101337045B/en active Active
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102120021A (en) * | 2011-03-11 | 2011-07-13 | 雷允上药业有限公司 | Detection method of concentrated pills for treating hyperplastic disease of breast |
| CN102120021B (en) * | 2011-03-11 | 2012-05-02 | 雷允上药业有限公司 | Detection method of concentrated pills for treating hyperplasia of mammary glands |
| CN102657814A (en) * | 2012-05-08 | 2012-09-12 | 华诚睿光（北京）科技发展有限公司 | Chinese medicinal preparation for treating intractable hyperplastic mastitis and preparation method thereof |
| CN104940483A (en) * | 2015-06-11 | 2015-09-30 | 宗秀红 | Traditional Chinese medicine for treating phlegm and blood stagnation type breast hyperplasia, and preparation method thereof |
| CN105194573A (en) * | 2015-11-03 | 2015-12-30 | 曹涛 | Traditional Chinese medicine patch for treating mammary gland diseases and promoting firmness of mammary glands |
| CN105944026A (en) * | 2016-06-24 | 2016-09-21 | 贵州盛世保康茶开发有限公司 | Miao-national medicine for treating hyperplasia of mammary glands |
| CN109381663A (en) * | 2017-08-08 | 2019-02-26 | 张君超 | A kind of Chinese medicine composition and preparation method thereof for treating the proliferation of mammary gland |
| CN109078154A (en) * | 2018-10-31 | 2018-12-25 | 中山市六安堂健康管理有限公司 | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland |
| CN114259550A (en) * | 2021-09-29 | 2022-04-01 | 哈尔滨康奇特科技有限公司 | Chinese medicinal prescription for preventing and treating breast diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101337045B (en) | 2011-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101337045B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN101564521A (en) | External plaster for treating hyperplasia of mammary glands | |
| CN103479962A (en) | Traditional Chinese medicine preparation for treating protrusion and hyperplasia of human cervical and lumbar vertebra | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
| CN101485862B (en) | Chinese medicament preparation for treating mastopathy | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN102940838B (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103006879B (en) | A traditional Chinese medicine composition for treating climacteric syndrome and its preparation method | |
| CN104922281A (en) | Traditional Chinese medicine composition of patch-type ointment for treating slow-transit constipation and preparation method thereof | |
| CN103610854A (en) | Traditional Chinese medicine (TCM) for treating allergic rhinitis | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
| CN102406879A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN1626185A (en) | Capsule for treating kidney disease | |
| CN104001100A (en) | Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition | |
| CN102949601B (en) | Medicine for treating alopecia areata and preparation method thereof | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN105998421A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN105687899A (en) | Traditional Chinese medicine composition for treating senile plaques | |
| CN102018814A (en) | Traditional Chinese medicinal preparation for treating alopecia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |